Showing results (411-420 of 588) with videos related to
Sort By:
Pageof 59
Nature Genetics|June 4, 2013
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasionGuocan Wang, Andrea Lunardi, Jiangwen Zhang, et al.Molecular Cancer Research : MCR|March 4, 2006
Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancerSimona Nanni, Carmen Priolo, Annalisa Grasselli, et al.Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.Carcinogenesis|June 26, 2010
Genetic variation in RNASEL associated with prostate cancer risk and progressionMara S Meyer, Kathryn L Penney, Jennifer R Stark, et al.Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
MYC regulation of a "poor-prognosis" metastatic cancer cell stateAnita Wolfer, Ben S Wittner, Daniel Irimia, et al.Cancer Research|November 23, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung CancerDeli Hong, Erik H Knelson, Yixiang Li, et al.Cancer|April 30, 2009
Innovations and challenges in renal cancer: summary statement from the Third Cambridge ConferenceMichael B Atkins, Ronald M Bukowski, Bernard J Escudier, et al.Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylaseSamuel K McBrayer, Benjamin A Olenchock, Gabriel J DiNatale, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlatesToni K Choueiri, Susanna Jacobus, Joaquim Bellmunt, et al.Pageof 59